Nebulization is a common and alternative method of drug delivery to the lungs. It is largely used in clinical settings for the treatment of acute respiratory ailments as well as for the long-term treatment of obstructive airway diseases such as chronic obstructive pulmonary disease, asthma, cystic fibrosis and bronchiectasis.
A nebulizer converts liquid medicine into vapour, aerosol or a mist so that it can be directly inhaled by the patient and effectively delivered to the respiratory tract. The main purpose of nebulization is to allow the medication to reach the lungs quickly and effortlessly, with very little need for coordination by the patient, a common challenge seen with handheld inhalers.
Hence, it is the preferred mode of drug delivery in the elderly, children and for patients who cannot effectively use handheld inhalers for various reasons.
Despite its wide acceptance and application, nebulization therapy is also viewed with an eye of criticism. Often the reasons for this is lack of knowledge, skills and misinformation about the use of nebulizers. With the aim to establish a judicious use of nebulization therapy and disseminate knowledge, Cipla started the public initiative called Good Nebulization Practice or simply, GNP.